MedTrace Logo

Prophylactic Ceftizoxime (Cefizox) for Elective Cesarean Delivery

NCT01347593 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2013-01-17

No results posted yet for this study

Summary

Ceftizoxime (Cefizox) will reduce post Cesarean delivery febrile morbidity.

Conditions

  • Caesarean

Interventions

DRUG

ceftizoxime

ceftizoxime (cefizox) injection either after clamping the cord

Sponsors & Collaborators

  • Ministry of Health, Sudan

    collaborator UNKNOWN

  • University of Khartoum

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • Sudan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01347593 on ClinicalTrials.gov